Pediatric-onset T2DM poses a much greater clinical challenge than its adult counterpart, as obese children face a fourfold higher risk and a markedly faster decline in β-cell function, insulin sensitivity (despite excessive insulin secretion), and a more rapid progression of microvascular and cardiovascular complications than youth with T1DM or adults with T2DM. This evidence concerns the gene INS and type 1 diabetes mellitus.